{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "08/14/2026",
      "update_type": "New",
      "initial_posting_date": "08/14/2026",
      "package_ndc": "63323-715-05",
      "generic_name": "Fulvestrant Injection",
      "contact_info": "888-386-1300",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "NDA210326"
        ],
        "brand_name": [
          "FULVESTRANT"
        ],
        "generic_name": [
          "FULVESTRANT"
        ],
        "manufacturer_name": [
          "Fresenius Kabi USA, LLC"
        ],
        "product_ndc": [
          "63323-715"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR"
        ],
        "substance_name": [
          "FULVESTRANT"
        ],
        "rxcui": [
          "727762"
        ],
        "spl_id": [
          "c584c51e-3ce0-4682-a4dd-d0ac149201a8"
        ],
        "spl_set_id": [
          "fabe9bd8-ac23-4df1-a89a-223d5cd38914"
        ],
        "package_ndc": [
          "63323-715-01",
          "63323-715-05"
        ],
        "nui": [
          "N0000175582",
          "N0000000145",
          "N0000000168"
        ],
        "pharm_class_epc": [
          "Estrogen Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Estrogen Receptor Antagonists [MoA]",
          "Selective Estrogen Receptor Modulators [MoA]"
        ],
        "unii": [
          "22X328QOC4"
        ]
      },
      "update_date": "08/14/2026",
      "therapeutic_category": [
        "Oncology"
      ],
      "dosage_form": "Injection",
      "presentation": "Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05)",
      "company_name": "Fresenius Kabi USA, LLC",
      "status": "To Be Discontinued"
    }
  ]
}